This Week at the FDA: A Win For a Potential Pancreatic Cancer and Narcolepsy Treatments and a New List of Pediatric Cancer Targets

Happy Friday everyone! The leaves are beginning to change, and so are ongoing activities at the FDA. This week, we're highlighting four FDA announcements we think you should  hear about.…

Continue Reading This Week at the FDA: A Win For a Potential Pancreatic Cancer and Narcolepsy Treatments and a New List of Pediatric Cancer Targets
Early Data Looks Favorable for CAR-T Cell Therapy as a Treatment For Acute Lymphocytic Leukemia
Alexas_Fotos / Pixabay

Early Data Looks Favorable for CAR-T Cell Therapy as a Treatment For Acute Lymphocytic Leukemia

According to a story from finanznachrichten.de, the Korean biopharmaceutical company Biocure Technology, Inc., recently announced the results of a pre-clinical trial that tested CAR-T cell therapy as a treatment for acute…

Continue Reading Early Data Looks Favorable for CAR-T Cell Therapy as a Treatment For Acute Lymphocytic Leukemia
Experimental Drug Halts Infantile Neuroaxonal Dystrophy in its Tracks
ashkhan2 / Pixabay

Experimental Drug Halts Infantile Neuroaxonal Dystrophy in its Tracks

According to a story from Market Screener, the pharmaceutical company Retrotope has recently released data that indicates that the company's experimental product RT001 is capable of halting disease progression for…

Continue Reading Experimental Drug Halts Infantile Neuroaxonal Dystrophy in its Tracks
Research Reveals Relationship Between Multiple Sclerosis and Digestive System Flora
qimono / Pixabay

Research Reveals Relationship Between Multiple Sclerosis and Digestive System Flora

According to a story from EurekAlert!, a recent study from the University of Zurich has illuminated the connection between the gastrointestinal flora and multiple sclerosis. The discovery illuminates the potential…

Continue Reading Research Reveals Relationship Between Multiple Sclerosis and Digestive System Flora

Patient Groups and the FDA Meet For Charcot-Marie-Tooth Disease Drug Development

According to a story from Charcot-Marie-Tooth News, a recent meeting between the US Food and Drug Administration (FDA) and patient advocacy groups took place to discuss the future development of…

Continue Reading Patient Groups and the FDA Meet For Charcot-Marie-Tooth Disease Drug Development
Close Menu